<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Co-Diagnostics (NASDAQ:CODX) Inc posted second-quarter results that saw pre-tax income of $11.9 million and year-over-year revenue gains driven by sales of the company’s Logix Smart COVID-19 Test. For the period ended June 30, 2021, the Salt Lake City, Utah-based molecular diagnostics company reported revenue of $27.4 million, up 13.8% from the second quarter in 2020.
...read full article on Proactive Investors
